Malvinder Mohan Singh and Shivinder Mohan Singh, the sons of Dr. Parvinder Singh, carried forward the entrepreneurial legacy of the Singh Group. Over the last 15 years, Malvinder and Shivinder have diversified the businesses across the healthcare and financial services sectors. The two brothers have guided the Group to new heights with their progressive and bold business strategies.
Malvinder Mohan Singh is a leading entrepreneur and one of the most
recognizable names in the healthcare sector. Currently, Executive
Chairman at Fortis Healthcare Limited & SRL Diagnostics Limited,
Malvinder has laid the foundation for a world-class healthcare ecosystem
in India. He is also the Chairman at Religare Enterprises Limited, one of
India’s leading diversified financial services groups.
As Executive Chairman, Fortis Healthcare Limited, he has strengthened the fabric of the organization, and enabled it to move ahead in realizing its purpose of saving and enriching lives and expanding access to high quality healthcare at Indian price points. He remains a strong believer in the India growth story, and under his leadership both Fortis and SRL are committed to transforming the Indian healthcare landscape by taking the next leap in clinical excellence and patient-centric care.
An intrinsic risk-taker and an optimistic entrepreneur, Malvinder is well-known for his ability to build businesses with impeccable focus on value creation and positive outcomes. He was instrumental in the creation and listing of the Religare Health Trust (RHT) on the Singapore Stock Exchange (SGX). With this vehicle, he created a perpetual source of funding for the business and helped Fortis to transition to an asset light business model. Previously, Malvinder was Chairman, MD and CEO of Ranbaxy Laboratories Ltd. and Chairman of the Board of Parkway Holdings. Through his strategic and bold business decisions he has helped unlock significant value for all shareholders in Ranbaxy, Parkway Holdings and Fortis’ international assets.
To fulfill the dream of a healthy nation, Malvinder has sown the seeds for curative and preventive healthcare for the underprivileged through Fortis Charitable Foundation, where he is a founder trustee. He passionately supports programmes that lay focus on women and children along with initiatives related to disaster-relief.
Recognized as a successful, young business leader, Malvinder represents India on entrepreneurship and healthcare at the World Economic Forum (WEF). He has been the youngest and the only person from Asia to Chair the healthcare Governance Council at WEF. He was also a member of the first batch of the Young Global Leaders, an initiative by WEF. At present, Malvinder is a member of the Board of Visitors at the Fuqua School of Business (Duke University, USA). He is currently an active member of the India-UK CEO’s Forum and the India-Africa Business Council. Until recently, from 2010 to 2016, he was also the co-chair of the India-Malaysia CEO’s Forum.
In India, Malvinder is the Vice President at the Federation of Indian Chambers of Commerce & Industry (FICCI). He is also the Chairman of the Swastha Bharath Task Force, set up by FICCI, that is working towards fulfilling the UN Sustainable Development Goals in healthcare. Malvinder is also the Chairman of the Services Council of Confederation of India Industry (CII) and member of the National Council.
As a healthcare entrepreneur, Malvinder has been conferred with numerous national and international awards over the last 15 years. A Doon School alumnus, Malvinder graduated in Economics honours from St. Stephen’s College, Delhi University. Later, he went on to earn an MBA degree from Fuqua School of Business, Duke University in USA.
Shivinder Mohan Singh, currently the Non-Executive Vice Chairman of Fortis Healthcare, has had a distinguished career as an entrepreneur and business leader, who, in a short span of under two decades, transformed the way private healthcare is delivered and shaped its evolution as an important and credible partner in India’s growth.
Shivinder was driven by the twin needs to create significant impact in the domain of healthcare delivery and by his vision, to bring world class standards of care delivery, at affordable prices, for the benefit of the people of India. His credo of “saving and enriching lives”, on a foundation of clinical excellence and distinctive patient care, continued to guide the evolution of Fortis as it took its rightful place as an acknowledged leader in healthcare delivery. During his executive stewardship of the organization, Fortis used several innovative formats to achieve unprecedented growth, combined with an unrelenting focus on clinical quality and standardization. Shivinder, simultaneously, also created a powerful platform for community outreach and CSR that included focus on helping the girl child, provision of medicare to under privileged children and contributing actively to the alleviation of pain and suffering during natural disasters.
Shivinder has played a prominent leadership role on several prominent industry platforms, including FICCI and Nathealth. He is credited with conceptualizing and leading the formation of Nathealth, India’s most prominent healthcare sector industry platform. He continues to be on the Board of Visitors of Duke University Business School, a Board Member of Aspen-Ananta Centre India, Governing Council Member of AIMA and member of the Advisory Board of AIESEC India, the world’s largest student-run organisation and a platform for young people to explore and develop their leadership potential for a positive impact on society.
In September 2015, Shivinder, in response to a higher calling, took a personal decision to take on full-time responsibility of SEWA at a Spiritual organisation that he has been associated with since his childhood. To Shivinder this was a logical next step - from saving and enriching lives he was inspired to do more direct service and give back to society. Consequently, he stepped down from his executive role at Fortis and transited to a non-executive role, as Vice Chairman, on the board of the company.